Insider Transactions in Q4 2024 at Nurix Therapeutics, Inc. (NRIX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,760
-17.02%
|
$120,960
$21.73 P/Share
|
|
Dec 02
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,760
+14.54%
|
$5,760
$1.86 P/Share
|
|
Nov 04
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,290
-10.49%
|
$82,250
$25.0 P/Share
|
|
Nov 04
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,290
+9.49%
|
$29,610
$9.57 P/Share
|
|
Nov 01
2024
|
Hans Van Houte Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,546
-9.51%
|
$85,104
$24.28 P/Share
|
|
Nov 01
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,760
-17.02%
|
$138,240
$24.28 P/Share
|
|
Nov 01
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,760
+14.54%
|
$5,760
$1.86 P/Share
|
|
Oct 30
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,182
-12.96%
|
$100,368
$24.3 P/Share
|
|
Oct 30
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,674
+7.91%
|
-
|
|
Oct 30
2024
|
Gwenn Hansen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,437
-6.35%
|
$82,488
$24.3 P/Share
|
|
Oct 30
2024
|
Gwenn Hansen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,957
+5.51%
|
-
|
|
Oct 30
2024
|
Hans Van Houte Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,368
-5.97%
|
$56,832
$24.3 P/Share
|
|
Oct 30
2024
|
Hans Van Houte Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,636
+7.26%
|
-
|
|
Oct 14
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,290
-11.8%
|
$82,250
$25.0 P/Share
|
|
Oct 14
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,290
+10.55%
|
$29,610
$9.57 P/Share
|
|
Oct 01
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,760
-9.6%
|
$126,720
$22.5 P/Share
|
|
Oct 01
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,760
+15.95%
|
$5,760
$1.86 P/Share
|